Previti, S., Ulrich, K., & Krauth-Siegel, R. (2017). Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical siseases (NTDs). Journal of medicinal chemistry, 60(16), . https://doi.org/10.1021/acs.jmedchem.7b00405
Chicago Style (17th ed.) CitationPreviti, Santo, Kathrin Ulrich, and Renate Krauth-Siegel. "Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Siseases (NTDs)." Journal of Medicinal Chemistry 60, no. 16 (2017). https://doi.org/10.1021/acs.jmedchem.7b00405.
MLA (9th ed.) CitationPreviti, Santo, et al. "Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Siseases (NTDs)." Journal of Medicinal Chemistry, vol. 60, no. 16, 2017, https://doi.org/10.1021/acs.jmedchem.7b00405.